Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D6KY5Q
|
|||
| Drug Name |
HLB-001
|
|||
| Indication | Methylmalonic acidemia [ICD-11: 5C50.E0] | Phase 1/2 | [1] | |
| Company |
LogicBio Therapeutics Lexington, MA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04581785) A Phase 1/2 Open-label Clinical Study of hLB-001 Gene Therapy in Pediatric Patients With Methylmalonic Acidemia Characterized by MMUT Mutations. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.